Dariohealth Corp Stock Performance
| DRIO Stock | USD 0.69 0.02 2.99% |
On a scale of 0 to 100, DarioHealth Corp holds a performance score of 3. The firm shows a Beta (market volatility) of -0.44, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning DarioHealth Corp are expected to decrease at a much lower rate. During the bear market, DarioHealth Corp is likely to outperform the market. Please check DarioHealth Corp's maximum drawdown, as well as the relationship between the expected short fall and rate of daily change , to make a quick decision on whether DarioHealth Corp's price patterns will revert.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in DarioHealth Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, DarioHealth Corp displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:20 | Dividend Date 2019-11-18 | Last Split Date 2019-11-18 |
1 | Acquisition by Dror Bacher of 346 shares of DarioHealth Corp subject to Rule 16b-3 | 12/26/2024 |
2 | Acquisition by Stern Adam K of 43850 shares of DarioHealth Corp subject to Rule 16b-3 | 12/27/2024 |
3 | Acquisition by Stern Adam K of 100 shares of DarioHealth Corp at 0.83 subject to Rule 16b-3 | 01/07/2025 |
4 | Acquisition by Kaplan Jon H. of tradable shares of DarioHealth Corp at 3.37 subject to Rule 16b-3 | 01/17/2025 |
5 | DarioHealth Announces 25.6M Private Placement Positioning the Company to Execute on Strategy Aiming to Reach Operational Cash Flow Positive Run Rate by the End ... | 01/21/2025 |
6 | PESG Report DarioHealth Positions Itself as a Market Leader in the Multi-Billion-Dollar Digital Health Transformation - Yahoo Canada Finance | 01/30/2025 |
7 | Market News Alert DarioHealth Secures Significant New Agreement, Expanding Growth in the 1.2 Trillion Dollar Cardiometabolic Market | 02/07/2025 |
8 | Acquisition by Kaplan Jon H. of 30000 shares of DarioHealth Corp subject to Rule 16b-3 | 02/24/2025 |
9 | Insider Trading | 02/25/2025 |
10 | DarioHealth to Report Fourth Quarter and Full Year 2024 Results on Monday, March 10, 2025 | 03/04/2025 |
11 | Market News Alert DarioHealth Beats Q4 Expectations, Reports 8 percent Growth in B2B Recurring Revenue | 03/10/2025 |
12 | Q4 2024 DarioHealth Corp Earnings Call Transcript | 03/11/2025 |
| Begin Period Cash Flow | 36.8 M |
DarioHealth |
DarioHealth Corp Relative Risk vs. Return Landscape
If you would invest 71.00 in DarioHealth Corp on December 17, 2024 and sell it today you would lose (4.00) from holding DarioHealth Corp or give up 5.63% of portfolio value over 90 days. DarioHealth Corp is currently generating 0.6376% in daily expected returns and assumes 13.1702% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than DarioHealth, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
DarioHealth Corp Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for DarioHealth Corp's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as DarioHealth Corp, and traders can use it to determine the average amount a DarioHealth Corp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0484
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | DRIO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 13.17 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.64 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average DarioHealth Corp is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DarioHealth Corp by adding it to a well-diversified portfolio.
DarioHealth Corp Fundamentals Growth
DarioHealth Stock prices reflect investors' perceptions of the future prospects and financial health of DarioHealth Corp, and DarioHealth Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DarioHealth Stock performance.
| Return On Equity | -0.75 | ||||
| Return On Asset | -0.35 | ||||
| Profit Margin | (2.06) % | ||||
| Operating Margin | (1.62) % | ||||
| Current Valuation | 29.41 M | ||||
| Shares Outstanding | 41.57 M | ||||
| Price To Earning | (2.30) X | ||||
| Price To Book | 0.38 X | ||||
| Price To Sales | 1.20 X | ||||
| Revenue | 27.04 M | ||||
| Gross Profit | 14.04 M | ||||
| EBITDA | (57.74 M) | ||||
| Net Income | (42.75 M) | ||||
| Cash And Equivalents | 67.95 M | ||||
| Cash Per Share | 2.96 X | ||||
| Total Debt | 30.19 M | ||||
| Debt To Equity | 0.23 % | ||||
| Current Ratio | 6.35 X | ||||
| Book Value Per Share | 1.87 X | ||||
| Cash Flow From Operations | (38.56 M) | ||||
| Earnings Per Share | (0.61) X | ||||
| Market Capitalization | 27.68 M | ||||
| Total Asset | 118.88 M | ||||
| Retained Earnings | (390.34 M) | ||||
| Working Capital | 23.89 M | ||||
| Current Asset | 4.29 M | ||||
| Current Liabilities | 1.69 M | ||||
About DarioHealth Corp Performance
By examining DarioHealth Corp's fundamental ratios, stakeholders can obtain critical insights into DarioHealth Corp's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that DarioHealth Corp is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 115.73 | 93.00 | |
| Return On Tangible Assets | 0.96 | 1.01 | |
| Return On Capital Employed | (0.56) | (0.59) | |
| Return On Assets | 0.34 | 0.36 | |
| Return On Equity | 0.57 | 0.54 |
Things to note about DarioHealth Corp performance evaluation
Checking the ongoing alerts about DarioHealth Corp for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for DarioHealth Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| DarioHealth Corp is way too risky over 90 days horizon | |
| DarioHealth Corp has some characteristics of a very speculative penny stock | |
| DarioHealth Corp appears to be risky and price may revert if volatility continues | |
| DarioHealth Corp has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 27.04 M. Net Loss for the year was (42.75 M) with profit before overhead, payroll, taxes, and interest of 14.04 M. | |
| DarioHealth Corp currently holds about 67.95 M in cash with (38.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 25.0% of the company shares are held by company insiders | |
| Latest headline from gurufocus.com: Q4 2024 DarioHealth Corp Earnings Call Transcript |
- Analyzing DarioHealth Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DarioHealth Corp's stock is overvalued or undervalued compared to its peers.
- Examining DarioHealth Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating DarioHealth Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of DarioHealth Corp's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of DarioHealth Corp's stock. These opinions can provide insight into DarioHealth Corp's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.61) | Revenue Per Share | Quarterly Revenue Growth 1.11 | Return On Assets | Return On Equity |
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.